![Gerald B. Pier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gerald B. Pier
Gründer bei Alopexx Enterprises LLC
Profil
Gerald B.
Pier was the founder of Alopexx, Inc. (founded in 2019) and served as the Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC.
Currently, Dr. Pier is a Professor at Harvard Medical School.
In terms of education, Dr. Pier holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of the Pacific.
Aktive Positionen von Gerald B. Pier
Unternehmen | Position | Beginn |
---|---|---|
Harvard Medical School | Corporate Officer/Principal | - |
Alopexx Enterprises LLC
![]() Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Gründer | - |
Ehemalige bekannte Positionen von Gerald B. Pier
Unternehmen | Position | Ende |
---|---|---|
ALOPEXX, INC. | Gründer | - |
Ausbildung von Gerald B. Pier
University of the Pacific | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Alopexx, Inc.
![]() Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
Alopexx Enterprises LLC
![]() Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Health Technology |